Hui Feng is the founder of Allink Biotherapeutics. Allink Biotherapeutics has raised $89M in total funding. Latest round: Series A. Based in Shanghai, China.
Hui Feng is the Founder and Chief Executive Officer of Allink Biotherapeutics, a clinical-stage biotechnology company. The company focuses on developing next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics for oncology and immunology diseases. Allink Biotherapeutics has successfully completed a $42 million Series A financing round and later secured an additional $47 million in Series A extension rounds to advance its global clinical programs and technology platforms.
Full founder directory · Investor directory · Company funding database · Fundraising library